Get started
Author

Thierry Lafont

Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody‐mediated disease
2013 · Florent Puisset, Mélanie White‐Koning, et al. · British Journal of Clinical Pharmacology · 84
PDF
Ribavirin pharmacokinetics in renal and liver transplant patients: evidence that it depends on renal function
2004 · Nassim Kamar, Etienne Chatelut, et al. · American Journal of Kidney Diseases · 83
Dexamethasone as a probe for docetaxel clearance
2004 · Florent Puisset, Etienne Chatelut, et al. · Cancer Chemotherapy and Pharmacology · 62
Factors for Hematopoietic Toxicity of Carboplatin: Refining the Targeting of Carboplatin Systemic Exposure
2010 · Antonin Schmitt, Laurence Gladieff, et al. · Journal of Clinical Oncology · 57
PDF
Cystatin C as a New Covariate to Predict Renal Elimination of Drugs
2005 · Fabienne Thomas, Sophie S??ronie-Vivien, et al. · Clinical Pharmacokinetics · 54
Population pharmacokinetics of oxaliplatin
2002 · Jean-Pierre Delord, Amine Umlil, et al. · Cancer Chemotherapy and Pharmacology · 45
Pharmacokinetics of heated intraperitoneal oxaliplatin
2007 · G. Ferron, S. Dattez, et al. · Cancer Chemotherapy and Pharmacology · 44
Determination of unbound fraction of imatinib and N-desmethyl imatinib, validation of an UPLC–MS/MS assay and ultrafiltration method
2012 · Cécile Arellano, Peggy Gandia, et al. · Journal of Chromatography B · 40
Development and validation of an UHPLC-MS/MS method for simultaneous quantification of ibrutinib and its dihydrodiol-metabolite in human cerebrospinal fluid
2018 · D. Beauvais, J.-F. Goossens, et al. · Journal of Chromatography B · 36
Serum concentrations of ribavirin and pegylated interferon and viral responses in patients infected with HIV and HCV
2008 · Florence Nicot, Florence Legrand‐Abravanel, et al. · Journal of Medical Virology · 36
Should therapeutic drug monitoring of the unbound fraction of imatinib and its main active metabolite N-desmethyl-imatinib be developed?
2012 · Peggy Gandia, Cécile Arellano, et al. · Cancer Chemotherapy and Pharmacology · 34
Determination of unbound fraction of pazopanib in vitro and in cancer patients reveals albumin as the main binding site
2015 · Diane-Charlotte Imbs, Marie-Noelle Paludetto, et al. · Investigational New Drugs · 32
Pharmacokinetics of pazopanib administered in combination with bevacizumab
2014 · Diane-Charlotte Imbs, Sylvie Négrier, et al. · Cancer Chemotherapy and Pharmacology · 26
Cetuximab pharmacokinetic/pharmacodynamics relationships in advanced head and neck carcinoma patients
2019 · Félicien Le Louedec, Catherine Alix‐Panabières, et al. · British Journal of Clinical Pharmacology · 24
Body Surface Area Dosing of High-Dose Methotrexate Should Be Reconsidered, Particularly in Overweight, Adult Patients
2020 · Fanny Gallais, Lucie Oberic, et al. · Therapeutic Drug Monitoring · 21
Simultaneous monitoring of pazopanib and its metabolites by UPLC–MS/MS
2018 · Marie-Noëlle Paludetto, Florent Puisset, et al. · Journal of Pharmaceutical and Biomedical Analysis · 19
Pharmacokinetic interaction between pazopanib and cisplatin regimen
2016 · Diane-Charlotte Imbs, Véronique Diéras, et al. · Cancer Chemotherapy and Pharmacology · 16
Dexamethasone as a probe for CYP3A4 metabolism: evidence of gender effect
2006 · F. Puisset, E. Chatelut, et al. · Cancer Chemotherapy and Pharmacology · 14
Therapeutic drug monitoring and dose adaptation of cisplatin in a newborn with hepatoblastoma: a case report
2018 · Fabienne Thomas, Gareth J. Veal, et al. · Cancer Chemotherapy and Pharmacology · 12
Biological Role of Pazopanib and Sunitinib Aldehyde Derivatives in Drug-Induced Liver Injury
2022 · Maud Maillard, Cécile Arellano, et al. · Metabolites · 5
PDF
Pharmacokinetic and Pharmacogenetic Study of Etoposide in High-Dose Protocol (TI-CE) for Advanced Germ Cell Tumors
2020 · Sotheara Moeung, Christine Chevreau, et al. · Pharmaceutical Research · 4
Individualization of high dose carboplatin based on therapeutic drug monitoring (TDM) for the treatment of testicular germ cell tumors (TICE protocol): Results of a multicenter phase II study.
2017 · Fabienne Thomas, Sotheara Moeung, et al. · Journal of Clinical Oncology · 1
L’interaction dansante : une place possible pour la rencontre entre les bébés et les artistes
2026 · Peng, Xianjing, Lafont, Thierry, et al. · Cairn.info
« Faire danse », « être chorégraphique ». Discussions autour de la danse et des tout-petits
2026 · Lafont, Thierry · Cairn.info
Therapeutic Drug Monitoring of Imatinib: Is There a Rationale for Also Quantifying Its Active Metabolite?
2024 · Clara Eschalier, Thierry Lafont, et al. · Chemotherapy
PDF
Works count: 27
Citation count: 749
H-index: 16
I10-index: 19
Year
Topic
Type